Yamato Kato

589 citations

25 papers · 423 indexed · h-index 13

Co-authors: Mitsuhiro Nakamura Junko Abe Natsumi Ueda Ryogo Umetsu Yasutomi Kinosada Yôko Nakayama Sayaka Sasaoka Toshinobu Matsui
Topics: Pharmacovigilance and Adverse Drug Reactions (11 papers)Pharmacy and Medical Practices (5 papers)Cardiac electrophysiology and arrhythmias (3 papers)
Cited by: Toxicology Pharmacology Geriatrics and Gerontology
Journals: PLoS ONE Molecules Tetrahedron Letters
Partner nations: Japan

In The Last Decade

Yamato Kato

25 papers receiving 416 citations

Peers

Countries citing papers authored by Yamato Kato

Since Specialization

Citations

This map shows the geographic impact of Yamato Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yamato Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yamato Kato more than expected).

Fields of papers citing papers by Yamato Kato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yamato Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yamato Kato. The network helps show where Yamato Kato may publish in the future.

Co-authorship network of co-authors of Yamato Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Yamato Kato. A scholar is included among the top collaborators of Yamato Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yamato Kato. Yamato Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Practical Epoxidation of Olefins Using Air and Ubiquitous Iron-Based Fluorous Salen Complex 2024 ·Molecules ·Yamato Kato,(unknown),(unknown),Takayuki Shioiri,Masato Matsugi	1
2	N-Methylated tetrapeptide synthesis via sequential filtration procedures based on TeflonTM immobilization utilizing the properties of fluorous 9-fluorenylmethyl ester 2023 ·Tetrahedron Letters ·(unknown),(unknown),Yamato Kato,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Takayuki Shioiri,Masato Matsugi	1
3	Asymmetric Henry Reaction Using Cobalt Complexes with Bisoxazoline Ligands Bearing Two Fluorous Tags 2023 ·Molecules ·(unknown),Yamato Kato,(unknown),Yoshitaka Hayashi,(unknown),(unknown),(unknown),Masato Matsugi	2
4	A Fluorous Proline Catalyst Immobilized on Teflon® for Highly Stereoselective Asymmetric Aldol Reactions 2021 ·Heterocycles ·Masato Matsugi,(unknown),(unknown),(unknown),Y. Kobayashi,(unknown),Yamato Kato,(unknown),(unknown),Takayuki Shioiri	2
5	Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network 2021 ·Frontiers in Pharmacology ·Ryogo Umetsu,Mizuki Tanaka,Yôko Nakayama,Yamato Kato,Natsumi Ueda,(unknown),Shiori Hasegawa,(unknown),(unknown),Kazuhiro Iguchi,Hiroyuki Tanaka,Eiichi Hinoi,Naoki Inagaki,Masatoshi Inden,(unknown),Mitsuhiro Nakamura	15
6	Development of Liquid-Chromatography Tandem-Mass-Spectrometry Method for Determining Environmental Contamination by Powdered Medicinal Drugs in Pharmacies 2021 ·INQUIRY The Journal of Health Care Organization Provision and Financing ·Shiori Hasegawa,Ryoichi Inaba,Hiroki Nakamura,Yamato Kato,Satoshi Nakao,Kouseki Hirade,(unknown),(unknown),(unknown),Kazuhiro Iguchi,(unknown),(unknown),Mitsuhiro Nakamura	1
7	Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database 2019 ·International Journal of Medical Sciences ·(unknown),Shiori Hasegawa,Satoshi Nakao,(unknown),Sayaka Sasaoka,Natsumi Ueda,Yamato Kato,Junko Abe,Takayuki Mōri,Tomoaki Yoshimura,Yasutomi Kinosada,Mitsuhiro Nakamura	31
8	Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database 2018 ·Journal of Pharmaceutical Health Care and Sciences ·Haruna Hatahira,Shiori Hasegawa,Sayaka Sasaoka,Yamato Kato,Junko Abe,Yumi Motooka,(unknown),(unknown),Satoshi Nakao,(unknown),(unknown),Kouseki Hirade,Takeshi Kato,Mitsuhiro Nakamura	14
9	Analysis of polypharmacy effects in older patients using Japanese Adverse Drug Event Report database 2017 ·PLoS ONE ·Junko Abe,Ryogo Umetsu,Hiroaki Uranishi,(unknown),(unknown),Yamato Kato,Natsumi Ueda,Sayaka Sasaoka,Haruna Hatahira,Yumi Motooka,(unknown),Mitsuhiro Nakamura	29
10	Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015 2017 ·International Journal of Medical Sciences ·Toshinobu Matsui,Ryogo Umetsu,Yamato Kato,(unknown),Sayaka Sasaoka,Yumi Motooka,Haruna Hatahira,Junko Abe,(unknown),(unknown),Yasutomi Kinosada,Mitsuhiro Nakamura	24
11	Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database 2016 ·Journal of Pharmaceutical Health Care and Sciences ·Junko Abe,Ryogo Umetsu,(unknown),Yamato Kato,Natsumi Ueda,Yôko Nakayama,(unknown),Toshinobu Matsui,Haruna Hatahira,Sayaka Sasaoka,Yumi Motooka,Hideaki Hara,Zenichiro Kato,Yasutomi Kinosada,Naoki Inagaki,Mitsuhiro Nakamura	71
12	Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases 2016 ·YAKUGAKU ZASSHI ·Sayaka Sasaoka,Toshinobu Matsui,Junko Abe,Ryogo Umetsu,Yamato Kato,Natsumi Ueda,(unknown),Yumi Motooka,Haruna Hatahira,Yasutomi Kinosada,Mitsuhiro Nakamura	18
13	Evaluation of Hypoglycemia with Oral Hypoglycemic Agents by Using Spontaneous Adverse Event Reports Database 2016 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Yumi Motooka,Ryogo Umetsu,Junko Abe,Natsumi Ueda,Yamato Kato,(unknown),Toshinobu Matsui,Sayaka Sasaoka,Haruna Hatahira,Yasutomi Kinosada,Mitsuhiro Nakamura	2
14	Risk Analysis of New-onset Impaired Glucose Tolerance with Statins by Using a Spontaneous Reporting Database of Adverse Events 2016 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Haruna Hatahira,Toshinobu Matsui,Yamato Kato,Natsumi Ueda,Junko Abe,Sayaka Sasaoka,Yumi Motooka,(unknown),Yasutomi Kinosada,(unknown),Mitsuhiro Nakamura	2
15	Analysis of the time-to-onset of osteonecrosis of jaw with bisphosphonate treatment using the data from a spontaneous reporting system of adverse drug events 2015 ·Journal of Pharmaceutical Health Care and Sciences ·Mitsuhiro Nakamura,Ryogo Umetsu,Junko Abe,Toshinobu Matsui,Natsumi Ueda,Yamato Kato,Sayaka Sasaoka,Kohei Tahara,Hirofumi Takeuchi,Yasutomi Kinosada	58
16	Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports 2015 ·Journal of Pharmaceutical Health Care and Sciences ·Yamato Kato,Ryogo Umetsu,Junko Abe,Natsumi Ueda,Yôko Nakayama,Yasutomi Kinosada,Mitsuhiro Nakamura	26
17	Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age 2015 ·International Journal of Medical Sciences ·Junko Abe,Ryogo Umetsu,Yamato Kato,Natsumi Ueda,Yôko Nakayama,Yukiya Suzuki,Toshiyuki Suzuki,Hideko Nagasawa,Yasutomi Kinosada,Mitsuhiro Nakamura	22
18	Adverse Event Signals of Interstitial Lung Disease in the FDA Adverse Event Reporting System (FAERS) Database and the Japanese Adverse Drug Event Report (JADER) Database 2015 ·Toshinobu Matsui,Ryogo Umetsu,Yamato Kato,Natsumi Ueda,Junko Abe,Yôko Nakayama,(unknown),Yasutomi Kinosada,Mitsuhiro Nakamura	4
19	Adverse Event Trends Associated with Over-the-counter Drugs: Data Mining of the Japanese Adverse Drug Event Report Database 2015 ·YAKUGAKU ZASSHI ·Ryogo Umetsu,Junko Abe,Natsumi Ueda,Yamato Kato,Yôko Nakayama,Yasutomi Kinosada,Mitsuhiro Nakamura	9
20	Association between Selective Serotonin Reuptake Inhibitor Therapy and Suicidality: Analysis of U.S. Food and Drug Administration Adverse Event Reporting System Data 2015 ·Biological and Pharmaceutical Bulletin ·Ryogo Umetsu,Junko Abe,Natsumi Ueda,Yamato Kato,Toshinobu Matsui,Yôko Nakayama,Yasutomi Kinosada,Mitsuhiro Nakamura	36

About Yamato Kato

Yamato Kato is a scholar working on Toxicology, Pharmacology and Geriatrics and Gerontology, having authored 25 papers that have together received 423 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (11 papers), Pharmacy and Medical Practices (5 papers) and Cardiac electrophysiology and arrhythmias (3 papers). The work is most often cited by research in Toxicology (136 citations), Pharmacology (69 citations) and Geriatrics and Gerontology (28 citations). Yamato Kato has collaborated with scholars based in Japan. Frequent co-authors include Mitsuhiro Nakamura, Junko Abe, Natsumi Ueda, Ryogo Umetsu, Yasutomi Kinosada, Yôko Nakayama, Sayaka Sasaoka, Toshinobu Matsui, Yumi Motooka and Haruna Hatahira. Their work appears in journals such as PLoS ONE, Molecules and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact